Rifamycin Impurity 7 | CAS 32259-67-9 - Request Quote
Rifamycin Impurity 7
| SZ CAT No: | SZ-R058015 |
| CAS No | 32259-67-9 |
| Mol.F. | C36H43NO12 |
| Mol.Wt. | 681.7 |
| Inv. Status | Synthesis on demand |
Synonym :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Rifamycin Impurity 7 is chemically . It is also known as 27-Demethoxy-27-hydroxyrifamycin S. Rifamycin Impurity 7 is supplied with detailed characterization data compliant with regulatory guideline. Rifamycin Impurity 7 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Rifamycin.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 32259-67-9
Purchase 32259-67-9
Order 32259-67-9
Enquire 32259-67-9
price of 32259-67-9
32259-67-9 Supplier
32259-67-9 Manufacturer
32259-67-9 Exporter
buy high quality Rifamycin Impurity 7
Purchase Rifamycin Impurity 7
Rifamycin Impurity 7 suppliers
Rifamycin Impurity 7 manufacturers
Rifamycin Impurity 7 price
Order Rifamycin Impurity 7
Enquire Rifamycin Impurity 7
Rifamycin Impurity 7 cost
Rifamycin Impurity 7 Supplier
Rifamycin Impurity 7 Distributor
Rifamycin Impurity 7 for Method Validation
Rifamycin Reference Standard
Rifamycin Impurity 7 for ANDA Filing
Rifamycin Impurity 7 for Forced Degradation Studies
Rifamycin Impurity 7 Identification Standards
Rifamycin Impurity 7 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


